Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

The pathways of secretory cargo export at the endoplasmic reticulum

  • Malhotra, Vivek
Palade's original model proposed that secretory cargo is transported between stable compartments via vesicles. However, recent findings challenge this view, suggesting that secretory pathway compartments are dynamic, with cargo itself dictating whether transfer occurs via vesicles or through the continuity and maturation of compartmental structures. At the heart of this process is TANGO1, a key component of a molecular machine that works in concert with COPII proteins to construct export routes tailored to the size and quantity of secretory cargo., I extend my heartfelt gratitude to Jeremy Thorner and Ishier Raote for their invaluable assistance in refining this text. I thank Agustin Lujan (Malhotra Lab, CRG) for providing Fig. 1 in this document. I acknowledge financial support from the following sources: Ministerio de Economía y Competitividad (IJCSEV-2012-0208, BFU2013-649 44188-P, and CSD2009-00016 to V.M.) and the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No 951146).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Editorial: Unconventional protein secretion: From basic mechanisms to dysregulation in disease

  • Chiritoiu, Marioara
  • Stewart, Sarah E.
  • Zhang, Min
  • Malhotra, Vivek
  • Villeneuve, Julien
MC acknowledges support from the Romanian Ministry of Research and Innovation, UEFISCDI grant TE156/2020 (PN-III-P1-1.1-TE-2019-1705). SES acknowledges support from the Australian Research Council, DE200100611. VM is an Institució Catalana de Recerca i Estudis Avançats professor at the Centre for Genomic Regulation. Work in the Malhotra lab is funded by grants from the Spanish Ministry of Economy and Competitiveness (Plan Nacional to VM: PID 2019-105518GB-I00) and the European Research Council Synergy Grant (ERC-2020-SyG - Proposal No. 951146). JV acknowledges support from the Fondation Vaincre Alzheimer, the association France Parkinson, CNRS, INSERM and the University of Montpellier.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Endoplasmic reticulum exit sites are segregated for secretion based on cargo size

  • Saxena, Sonashree
  • Foresti, Ombretta
  • Liu, Aofei
  • Androulaki, Stefania
  • Rodriguez, Maria Pena
  • Raote, Ishier
  • Aridor, Meir
  • Cui, Bianxiao
  • Malhotra, Vivek
TANGO1, TANGO1-Short, and cTAGE5 form stable complexes at the endoplasmic reticulum exit sites (ERES) to preferably export bulky cargoes. Their C-terminal proline-rich domain (PRD) binds Sec23A and affects COPII assembly. The PRD in TANGO1-Short was replaced with light-responsive domains to control its binding to Sec23A in U2OS cells (human osteosarcoma). TANGO1-ShortΔPRD was dispersed in the ER membrane but relocated rapidly, reversibly, to pre-existing ERES by binding to Sec23A upon light activation. Prolonged binding between the two, concentrated ERES in the juxtanuclear region, blocked cargo export and relocated ERGIC53 into the ER, minimally impacting the Golgi complex organization. Bulky collagen VII and endogenous collagen I were collected at less than 47% of the stalled ERES, whereas small cargo molecules were retained uniformly at almost all the ERES. We suggest that ERES are segregated to handle cargoes based on their size, permitting cells to traffic them simultaneously for optimal secretion., We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033); the Generalitat de Catalunya through the CERCA programme and the EMBL partnership; Ministerio de Ciencia e Innovación (Ramon y Cajal Fellow, RYC-2016-20919) to O.F.;Ministerio de Economía y Competitividad: IJCI-2017-34751 and Fondation pour la Recherche Medicale (FRM), AJE202210016216 to I.R.; Ministerio de Economía y Competitividad:SEV-2012-0208, BFU2013-44188-P (funded by Agencia Estatal de Investigación [AEI]), and CSD2009-00016 (CONSOLIDER - INGENIO 2010) to V.M. The National Institutes of Health NIH (R35GM141598, (R01NS121934) and seed grant from the Stanford Wu Tsai Neuroscience Institute to B.C. and A.L. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program under grant agreement no. 951146. This publication is part of the project TARTAFI (ref. PDC2021-121870-I00), funded by MCIN/AEI/10.13039/501100011033, by “ERDF A way of making Europe,” and by the “European Union NextGenerationEU/PRTR.”.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Pla2g12b drives expansion of triglyceride-rich lipoproteins

  • Thierer, James H.
  • Foresti, Ombretta
  • Yadav, Pradeep Kumar
  • Wilson, Meredith H.
  • Moll, Tabea O. C.
  • Shen, Meng-Chieh
  • Busch-Nentwich, Elisabeth M.
  • Morash, Margaret
  • Mohlke, Karen L.
  • Rawls, John F.
  • Malhotra, Vivek
  • Hussain, M. Mahmood
  • Farber, Steven A.
Vertebrates transport hydrophobic triglycerides through the circulatory system by packaging them within amphipathic particles called Triglyceride-Rich Lipoproteins. Yet, it remains largely unknown how triglycerides are loaded onto these particles. Mutations in Phospholipase A2 group 12B (PLA2G12B) are known to disrupt lipoprotein homeostasis, but its mechanistic role in this process remains unclear. Here we report that PLA2G12B channels lipids within the lumen of the endoplasmic reticulum into nascent lipoproteins. This activity promotes efficient lipid secretion while preventing excess accumulation of intracellular lipids. We characterize the functional domains, subcellular localization, and interacting partners of PLA2G12B, demonstrating that PLA2G12B is calcium-dependent and tightly associated with the membrane of the endoplasmic reticulum. We also detect profound resistance to atherosclerosis in PLA2G12B mutant mice, suggesting an evolutionary tradeoff between triglyceride transport and cardiovascular disease risk. Here we identify PLA2G12B as a key driver of triglyceride incorporation into vertebrate lipoproteins., This work was financially supported by National Institutes of Health grants R01DK093399 (S.A.F., J.F.R), R01HL158054 (S.A.F. and M.M.H.), F31HL149174 (T.O.C.M.), F31HL139338 (J.H.T.), the Mathers Foundation (S.A.F.), the Carnegie Institution for Science endowment (S.A.F.), Ministerio de Economía y Competitividad (RYC-2016-20919, O.F.), Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (PID2019-105518GB-I00, V.M.), and the European Research Council (ERC-2020-SyG-Proposal No. 951146, V.M.).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

TANGO2 is an acyl-CoA binding protein

  • Lujan, Agustin Leonardo
  • Foresti, Ombretta
  • Wojnacki, José
  • Bigliani, Gonzalo
  • Brouwers, Nathalie
  • Pena, Maria Jesus
  • Androulaki, Stefania
  • Hashidate-Yoshida, Tomomi
  • Kalyukina, Maria
  • Novoselov, Sergey S.
  • Shindou, Hideo
  • Malhotra, Vivek
Loss of TANGO2 in humans precipitates metabolic crises during periods of heightened energy demand, such as fasting, infections, or high fever. TANGO2 has been implicated in various functions, including lipid metabolism and heme transport, and its cellular localization remains uncertain. In our study, we demonstrate that TANGO2 localizes to the mitochondrial lumen via a structural region containing LIL residues. Mutations in these LIL residues cause TANGO2 to relocate to the periphery of lipid droplets. We further show that purified TANGO2 binds acyl-coenzyme A, and mutations in the highly conserved NRDE sequence of TANGO2 inhibit this binding. Collectively, our findings suggest that TANGO2 serves as an acyl-coenzyme A binding protein. These insights may provide new avenues for addressing the severe cardiomyopathies and rhabdomyolysis associated with defective TANGO2 in humans.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

TANGO1 inhibitors reduce collagen secretion and limit tissue scarring

  • Raote, Ishier
  • Häkkinen, Hanna-Maria
  • Vibe, Carine
  • Broadbent, Katrina
  • Carolis, Carlo
  • Ruprecht, Verena
  • Malhotra, Vivek
Uncontrolled secretion of ECM proteins, such as collagen, can lead to excessive scarring and fibrosis and compromise tissue function. Despite the widespread occurrence of fibrotic diseases and scarring, effective therapies are lacking. A promising approach would be to limit the amount of collagen released from hyperactive fibroblasts. We have designed membrane permeant peptide inhibitors that specifically target the primary interface between TANGO1 and cTAGE5, an interaction that is required for collagen export from endoplasmic reticulum exit sites (ERES). Application of the peptide inhibitors leads to reduced TANGO1 and cTAGE5 protein levels and a corresponding inhibition in the secretion of several ECM components, including collagens. Peptide inhibitor treatment in zebrafish results in altered tissue architecture and reduced granulation tissue formation during cutaneous wound healing. The inhibitors reduce secretion of several ECM proteins, including collagens, fibrillin and fibronectin in human dermal fibroblasts and in cells obtained from patients with a generalized fibrotic disease (scleroderma). Taken together, targeted interference of the TANGO1-cTAGE5 binding interface could enable therapeutic modulation of ERES function in ECM hypersecretion, during wound healing and fibrotic processes., The authors thank the CRG Advanced Light Microscopy Unit (ALMU), the Protein Technologies Unit, and the CRG/UPF Flow Cytometry Unit. Susanne Neumann (Cologne) provided excellent technical assistance. We would like to thank Prof. Dr. Pia Moinzadeh for obtaining the skin biopsies. The authors acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya and the Alexander v. Humboldt foundation. We acknowledge financial support from the following sources: Ministerio de Economía y Competitividad (SEV-2012-0208, BFU2013-44188-P, CSD2009-00016 to V.M.); Deutsche Forschungsgemeinschaft (ID 468236352) and CMMC Cologne to T.K and V.M. V.R. acknowledges financial support from the Ministerio de Ciencia y Innovacion through the Plan Nacional (PID2020-117011GB-I00). This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 951146). This publication is part of the Project TARTAFI (Ref. PDC2021-121870-I00), funded by MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/PRTR. This work was supported by the Fondation pour la Recherche Médicale, (FRM) AJE202210016216 to I.R. M.C, G.C, F.C, J.A, and PL-A acknowledge funding from Fundació CELLEX; Ministerio de Economıa y Competitividad - Severo Ochoa programme for Centres of Excellence in R&D (CEX2019-000910-S); CERCA programme and Laserlab-Europe (871124); Ministerio de Ciencia e Innovación (MCIN/AEI/10.13039/501100011033); and Fondo Social Europeo (PRE2020-095721, M.C). The SLN facility corresponds to a “Grup reconegut 2021 SGR 01456 pel Departament de Recerca i Universitats de la Generalitat de Catalunya”. F.C. acknowledges support from the Government of Spain (RYC-2017–22227, PID2019-106232RB-I00/10.13039/501100011033/110198RB-I00).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

A model for collagen secretion by intercompartmental continuities

  • Bunel, Louis
  • Pincet, Lancelot
  • Malhotra, Vivek
  • Raote, Ishier
  • Pincet, Frederic
Newly synthesized secretory proteins are exported from the endoplasmic reticulum (ER) at specialized subcompartments called exit sites (ERES). Cargoes like procollagen are too large for export by the standard COPII-coated vesicle of 60 nm average diameter. We have previously suggested that procollagen is transported from the ER to the next secretory organelle, the ER-Golgi intermediate compartment (ERGIC), in TANGO1-dependent interorganelle tunnels. In the theoretical model presented here, we suggest that intrinsically disordered domains of TANGO1 in the ER lumen induce an entropic contraction, which exerts a force that draws procollagen toward the ERES. Within this framework, molecular gradients of pH and/or HSP47 between the ER and ERGIC create a force in the order of tens of femto-Newtons. This force is substantial enough to propel procollagen from the ER at a speed of approximately 1 nm · s-1. This calculated speed and the quantities of collagen secreted are similar to its observed physiological secretion rate in fibroblasts, consistent with the proposal that ER export is the rate-limiting step for procollagen secretion. Hence, the mechanism we propose is theoretically adequate to explain how cells can utilize molecular gradients and export procollagens at a rate commensurate with physiological needs., This work was supported by the LiquOrg synergy grant, ERC-2020-SyG-951146, awarded to V.M. and F.P. V.M. acknowledges the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya. I.R. acknowledges the support of Fondation pour la Recherche Médicale (grant AJE202210016216).
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Defects in lipid homeostasis reflect the function of TANGO2 in phospholipid and neutral lipid metabolism

  • Lujan, Agustin Leonardo
  • Foresti, Ombretta
  • Sugden, Conor
  • Brouwers, Nathalie
  • Farre, Alex Mateo
  • Vignoli, Alessio
  • Azamian, Mahshid
  • Turner, Alicia
  • Wojnacki, José
  • Malhotra, Vivek
We show that TANGO2 in mammalian cells localizes predominantly to mitochondria and partially at mitochondria sites juxtaposed to lipid droplets (LDs) and the endoplasmic reticulum. HepG2 cells and fibroblasts of patients lacking TANGO2 exhibit enlarged LDs. Quantitative lipidomics revealed a marked increase in lysophosphatidic acid (LPA) and a concomitant decrease in its biosynthetic precursor phosphatidic acid (PA). These changes were exacerbated in nutrient-starved cells. Based on our data, we suggest that TANGO2 function is linked to acyl-CoA metabolism, which is necessary for the acylation of LPA to generate PA. The defect in acyl-CoA availability impacts the metabolism of many other fatty acids, generates high levels of reactive oxygen species, and promotes lipid peroxidation. We suggest that the increased size of LDs is a combination of enrichment in peroxidized lipids and a defect in their catabolism. Our findings help explain the physiological consequence of mutations in TANGO2 that induce acute metabolic crises, including rhabdomyolysis, cardiomyopathy, and cardiac arrhythmias, often leading to fatality upon starvation and stress., We thank all members of the Malhotra laboratory for valuable discussions and critical reading of the manuscript. We thank Aida Rodriguez for advice with ROS analysis; Albert Pol and Albert Herms for advice with lipid metabolic experiments; the staff of the CRG/UPF Flow Cytometry Unit for advice with flow cytometry analysis and the staff of the CRG Advanced Light Microscopy Unit for invaluable technical help. We acknowledge the support of the Spanish Ministry of Science, the Centro de Excelencia Severo Ochoa, and the CERCA Programme/Generalitat de Catalunya. V Malhotra is an Institució Catalana de Recerca i Estudis Avançats professor at the Centre for Genomic Regulation. V Malhotra is an Institució Catalana de Recerca i Estudis Avançats professor at the Centre for Genomic Regulation Work in the Malhotra lab is funded by grants from the Spanish Ministry of Economy and Competitiveness (Plan Nacional to VM: PID2019-105518GB-I00) and the European Research Council Synergy Grant (ERC-2020-SyG-Proposal No. 951146). AL is funded by the European Molecular Biology Organization (EMBO ALTF 659-2021), JW is funded by the European Research Council (H2020-MSCA-IF-2019-894115). OF is funded by the Ramon y Cajal program (RYC-2016-20919). This work reflects only the authors’ views, and the EU Community is not liable for any use that may be made of the information contained therein.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Towards a unified framework for the function of endoplasmic reticulum exit sites

  • Farhan, Hesso
  • Raote, Ishier
  • Campelo, Felix
  • Ge, Liang
  • Hirschberg, Koret
  • Forrester, Alison
  • Zanetti, Giulia
  • Lippincott-Schwartz, Jennifer
  • Pastor-Pareja, José Carlos
  • Perez, Franck
  • Saito, Kota
  • Malhotra, Vivek
Endoplasmic reticulum exit sites (ERES) are specialized, ribosome-free ER subdomains that serve as dynamic portals for COPII-mediated export of proteins from the ER. Beyond their role in the secretory pathway, ERES are implicated in diverse processes, including autophagy and the maturation of lipid droplets, highlighting their functional plasticity. ERES integrate cargo load, membrane tension and spatial cues to remodel their architecture and function in real time. This Roadmap synthesizes our current knowledge on the biogenesis, structural diversity and regulatory logic of ERES. We highlight key unanswered questions in the field, particularly concerning how ERES integrate signals to coordinate protein trafficking under varying cellular states. Finally, we propose a multidisciplinary framework - leveraging advances in high-resolution imaging, synthetic reconstitution and computational modelling - to delineate the principles governing the function and plasticity of ERES. Understanding these mechanisms holds significant potential for developing targeted therapeutic strategies in diseases linked to trafficking dysfunction., I.R. acknowledges the support of Fondation pour la Recherche Médicale (AJE202210016216), Agence Nationale de la Recherche (MatSec) and the Fondation ARC. L.G. is supported by NSFC (92254302, 32130023 and 32225013), New Cornerstone Science Foundation, and Tsinghua Dushi Program. Work in the J.C.P.-P. laboratory is funded by grant PID2021-122119NB-I00 from Ministerio de Ciencia, Innovación y Universidades and the ‘Severo Ochoa’ Program for Centers of Excellence CEX2021-001165-S. F.C. is supported by the State Research Agency (AEI) PID2022-138282NB-I00 project funded by the MCIN/AEI/10.13039/501100011033/FEDER, UE. V.M. is supported by grants IJCSEV-2012-0208, BFU2013-649 44188-P and CSD2009-00016/Ministerio de Economía y Competitividad (Ministry of Economy and Competitiveness) 951146/EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science — European Research Council). K.S. is supported by JSPS Grants-in-Aid for Scientific Research (23K27123, 24K22065) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. H.F. acknowledges support by grants from the Austrian Science Foundation (FWF) (10.55776/FG20, 10.55776/P35832, 10.55776/P36600 and 10.55776/PAT1562424). A.F. is a Chercheur Qualifiée of Fonds de la Recherche Scientifique — FNRS and investigator of the WEL Research Institute. Work in the Forrester laboratory is supported by an F.R.S.-FNRS Incentive for Scientific Research Grant (MIS: F.4518.23) and a WELBIO starting grant (X.2509.24). Work in the Perez laboratory work is supported by Labex Cell(n)Scale (ANR-10-LBX-0038, part of the IDEX PSL ANR-10-IDEX-0001-02), by ANR grants ANR-23-CE44-0014-02, ANR-22-CE14-0066-01 and ANR-19-CE13-0006-03, and by the Fondation pour la Recherche Médicale (EQU202503019991). G.Z. acknowledges support from the European Research Council (ERC-StG-2019 grant 852915) and UKRI — Medical Research Council (MRC grant MR/Z504312/1)., With funding from the Spanish government through the "Severo Ochoa Centre of Excelence" accreditation (CEX2021-001165-S), Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

The pathways of secretory cargo export at the endoplasmic reticulum

  • Malhotra, Vivek
Palade's original model proposed that secretory cargo is transported between stable compartments via vesicles. However, recent findings challenge this view, suggesting that secretory pathway compartments are dynamic, with cargo itself dictating whether transfer occurs via vesicles or through the continuity and maturation of compartmental structures. At the heart of this process is TANGO1, a key component of a molecular machine that works in concert with COPII proteins to construct export routes tailored to the size and quantity of secretory cargo., I extend my heartfelt gratitude to Jeremy Thorner and Ishier Raote for their invaluable assistance in refining this text. I thank Agustin Lujan (Malhotra Lab, CRG) for providing Fig. 1 in this document. I acknowledge financial support from the following sources: Ministerio de Economía y Competitividad (IJCSEV-2012-0208, BFU2013-649 44188-P, and CSD2009-00016 to V.M.) and the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation program (grant agreement No 951146).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Defects in lipid homeostasis reflect the function of TANGO2 in phospholipid and neutral lipid metabolism

  • Lujan, Agustin Leonardo
  • Foresti, Ombretta
  • Sugden, Conor
  • Brouwers, Nathalie
  • Farre, Alex Mateo
  • Vignoli, Alessio
  • Azamian, Mahshid
  • Turner, Alicia
  • Wojnacki, José
  • Malhotra, Vivek
We show that TANGO2 in mammalian cells localizes predominantly to mitochondria and partially at mitochondria sites juxtaposed to lipid droplets (LDs) and the endoplasmic reticulum. HepG2 cells and fibroblasts of patients lacking TANGO2 exhibit enlarged LDs. Quantitative lipidomics revealed a marked increase in lysophosphatidic acid (LPA) and a concomitant decrease in its biosynthetic precursor phosphatidic acid (PA). These changes were exacerbated in nutrient-starved cells. Based on our data, we suggest that TANGO2 function is linked to acyl-CoA metabolism, which is necessary for the acylation of LPA to generate PA. The defect in acyl-CoA availability impacts the metabolism of many other fatty acids, generates high levels of reactive oxygen species, and promotes lipid peroxidation. We suggest that the increased size of LDs is a combination of enrichment in peroxidized lipids and a defect in their catabolism. Our findings help explain the physiological consequence of mutations in TANGO2 that induce acute metabolic crises, including rhabdomyolysis, cardiomyopathy, and cardiac arrhythmias, often leading to fatality upon starvation and stress., We thank all members of the Malhotra laboratory for valuable discussions and critical reading of the manuscript. We thank Aida Rodriguez for advice with ROS analysis; Albert Pol and Albert Herms for advice with lipid metabolic experiments; the staff of the CRG/UPF Flow Cytometry Unit for advice with flow cytometry analysis and the staff of the CRG Advanced Light Microscopy Unit for invaluable technical help. We acknowledge the support of the Spanish Ministry of Science, the Centro de Excelencia Severo Ochoa, and the CERCA Programme/Generalitat de Catalunya. V Malhotra is an Institució Catalana de Recerca i Estudis Avançats professor at the Centre for Genomic Regulation. V Malhotra is an Institució Catalana de Recerca i Estudis Avançats professor at the Centre for Genomic Regulation Work in the Malhotra lab is funded by grants from the Spanish Ministry of Economy and Competitiveness (Plan Nacional to VM: PID2019-105518GB-I00) and the European Research Council Synergy Grant (ERC-2020-SyG-Proposal No. 951146). AL is funded by the European Molecular Biology Organization (EMBO ALTF 659-2021), JW is funded by the European Research Council (H2020-MSCA-IF-2019-894115). OF is funded by the Ramon y Cajal program (RYC-2016-20919). This work reflects only the authors’ views, and the EU Community is not liable for any use that may be made of the information contained therein.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

TANGO2 is an acyl-CoA binding protein

  • Lujan, Agustin Leonardo
  • Foresti, Ombretta
  • Wojnacki, José
  • Bigliani, Gonzalo
  • Brouwers, Nathalie
  • Pena, Maria Jesus
  • Androulaki, Stefania
  • Hashidate-Yoshida, Tomomi
  • Kalyukina, Maria
  • Novoselov, Sergey S.
  • Shindou, Hideo
  • Malhotra, Vivek
Loss of TANGO2 in humans precipitates metabolic crises during periods of heightened energy demand, such as fasting, infections, or high fever. TANGO2 has been implicated in various functions, including lipid metabolism and heme transport, and its cellular localization remains uncertain. In our study, we demonstrate that TANGO2 localizes to the mitochondrial lumen via a structural region containing LIL residues. Mutations in these LIL residues cause TANGO2 to relocate to the periphery of lipid droplets. We further show that purified TANGO2 binds acyl-coenzyme A, and mutations in the highly conserved NRDE sequence of TANGO2 inhibit this binding. Collectively, our findings suggest that TANGO2 serves as an acyl-coenzyme A binding protein. These insights may provide new avenues for addressing the severe cardiomyopathies and rhabdomyolysis associated with defective TANGO2 in humans.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Pla2g12b drives expansion of triglyceride-rich lipoproteins

  • Thierer, James H.
  • Foresti, Ombretta
  • Yadav, Pradeep Kumar
  • Wilson, Meredith H.
  • Moll, Tabea O. C.
  • Shen, Meng-Chieh
  • Busch-Nentwich, Elisabeth M.
  • Morash, Margaret
  • Mohlke, Karen L.
  • Rawls, John F.
  • Malhotra, Vivek
  • Hussain, M. Mahmood
  • Farber, Steven A.
Vertebrates transport hydrophobic triglycerides through the circulatory system by packaging them within amphipathic particles called Triglyceride-Rich Lipoproteins. Yet, it remains largely unknown how triglycerides are loaded onto these particles. Mutations in Phospholipase A2 group 12B (PLA2G12B) are known to disrupt lipoprotein homeostasis, but its mechanistic role in this process remains unclear. Here we report that PLA2G12B channels lipids within the lumen of the endoplasmic reticulum into nascent lipoproteins. This activity promotes efficient lipid secretion while preventing excess accumulation of intracellular lipids. We characterize the functional domains, subcellular localization, and interacting partners of PLA2G12B, demonstrating that PLA2G12B is calcium-dependent and tightly associated with the membrane of the endoplasmic reticulum. We also detect profound resistance to atherosclerosis in PLA2G12B mutant mice, suggesting an evolutionary tradeoff between triglyceride transport and cardiovascular disease risk. Here we identify PLA2G12B as a key driver of triglyceride incorporation into vertebrate lipoproteins., This work was financially supported by National Institutes of Health grants R01DK093399 (S.A.F., J.F.R), R01HL158054 (S.A.F. and M.M.H.), F31HL149174 (T.O.C.M.), F31HL139338 (J.H.T.), the Mathers Foundation (S.A.F.), the Carnegie Institution for Science endowment (S.A.F.), Ministerio de Economía y Competitividad (RYC-2016-20919, O.F.), Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (PID2019-105518GB-I00, V.M.), and the European Research Council (ERC-2020-SyG-Proposal No. 951146, V.M.).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

A model for collagen secretion by intercompartmental continuities

  • Bunel, Louis
  • Pincet, Lancelot
  • Malhotra, Vivek
  • Raote, Ishier
  • Pincet, Frederic
Newly synthesized secretory proteins are exported from the endoplasmic reticulum (ER) at specialized subcompartments called exit sites (ERES). Cargoes like procollagen are too large for export by the standard COPII-coated vesicle of 60 nm average diameter. We have previously suggested that procollagen is transported from the ER to the next secretory organelle, the ER-Golgi intermediate compartment (ERGIC), in TANGO1-dependent interorganelle tunnels. In the theoretical model presented here, we suggest that intrinsically disordered domains of TANGO1 in the ER lumen induce an entropic contraction, which exerts a force that draws procollagen toward the ERES. Within this framework, molecular gradients of pH and/or HSP47 between the ER and ERGIC create a force in the order of tens of femto-Newtons. This force is substantial enough to propel procollagen from the ER at a speed of approximately 1 nm · s-1. This calculated speed and the quantities of collagen secreted are similar to its observed physiological secretion rate in fibroblasts, consistent with the proposal that ER export is the rate-limiting step for procollagen secretion. Hence, the mechanism we propose is theoretically adequate to explain how cells can utilize molecular gradients and export procollagens at a rate commensurate with physiological needs., This work was supported by the LiquOrg synergy grant, ERC-2020-SyG-951146, awarded to V.M. and F.P. V.M. acknowledges the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya. I.R. acknowledges the support of Fondation pour la Recherche Médicale (grant AJE202210016216).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Endoplasmic reticulum exit sites are segregated for secretion based on cargo size

  • Saxena, Sonashree
  • Foresti, Ombretta
  • Liu, Aofei
  • Androulaki, Stefania
  • Rodriguez, Maria Pena
  • Raote, Ishier
  • Aridor, Meir
  • Cui, Bianxiao
  • Malhotra, Vivek
TANGO1, TANGO1-Short, and cTAGE5 form stable complexes at the endoplasmic reticulum exit sites (ERES) to preferably export bulky cargoes. Their C-terminal proline-rich domain (PRD) binds Sec23A and affects COPII assembly. The PRD in TANGO1-Short was replaced with light-responsive domains to control its binding to Sec23A in U2OS cells (human osteosarcoma). TANGO1-ShortΔPRD was dispersed in the ER membrane but relocated rapidly, reversibly, to pre-existing ERES by binding to Sec23A upon light activation. Prolonged binding between the two, concentrated ERES in the juxtanuclear region, blocked cargo export and relocated ERGIC53 into the ER, minimally impacting the Golgi complex organization. Bulky collagen VII and endogenous collagen I were collected at less than 47% of the stalled ERES, whereas small cargo molecules were retained uniformly at almost all the ERES. We suggest that ERES are segregated to handle cargoes based on their size, permitting cells to traffic them simultaneously for optimal secretion., We acknowledge the support of the Spanish Ministry of Science and Innovation through the Centro de Excelencia Severo Ochoa (CEX2020-001049-S, MCIN/AEI/10.13039/501100011033); the Generalitat de Catalunya through the CERCA programme and the EMBL partnership; Ministerio de Ciencia e Innovación (Ramon y Cajal Fellow, RYC-2016-20919) to O.F.;Ministerio de Economía y Competitividad: IJCI-2017-34751 and Fondation pour la Recherche Medicale (FRM), AJE202210016216 to I.R.; Ministerio de Economía y Competitividad:SEV-2012-0208, BFU2013-44188-P (funded by Agencia Estatal de Investigación [AEI]), and CSD2009-00016 (CONSOLIDER - INGENIO 2010) to V.M. The National Institutes of Health NIH (R35GM141598, (R01NS121934) and seed grant from the Stanford Wu Tsai Neuroscience Institute to B.C. and A.L. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program under grant agreement no. 951146. This publication is part of the project TARTAFI (ref. PDC2021-121870-I00), funded by MCIN/AEI/10.13039/501100011033, by “ERDF A way of making Europe,” and by the “European Union NextGenerationEU/PRTR.”.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

TANGO1 inhibitors reduce collagen secretion and limit tissue scarring

  • Raote, Ishier
  • Häkkinen, Hanna-Maria
  • Vibe, Carine
  • Broadbent, Katrina
  • Carolis, Carlo
  • Ruprecht, Verena
  • Malhotra, Vivek
Uncontrolled secretion of ECM proteins, such as collagen, can lead to excessive scarring and fibrosis and compromise tissue function. Despite the widespread occurrence of fibrotic diseases and scarring, effective therapies are lacking. A promising approach would be to limit the amount of collagen released from hyperactive fibroblasts. We have designed membrane permeant peptide inhibitors that specifically target the primary interface between TANGO1 and cTAGE5, an interaction that is required for collagen export from endoplasmic reticulum exit sites (ERES). Application of the peptide inhibitors leads to reduced TANGO1 and cTAGE5 protein levels and a corresponding inhibition in the secretion of several ECM components, including collagens. Peptide inhibitor treatment in zebrafish results in altered tissue architecture and reduced granulation tissue formation during cutaneous wound healing. The inhibitors reduce secretion of several ECM proteins, including collagens, fibrillin and fibronectin in human dermal fibroblasts and in cells obtained from patients with a generalized fibrotic disease (scleroderma). Taken together, targeted interference of the TANGO1-cTAGE5 binding interface could enable therapeutic modulation of ERES function in ECM hypersecretion, during wound healing and fibrotic processes., The authors thank the CRG Advanced Light Microscopy Unit (ALMU), the Protein Technologies Unit, and the CRG/UPF Flow Cytometry Unit. Susanne Neumann (Cologne) provided excellent technical assistance. We would like to thank Prof. Dr. Pia Moinzadeh for obtaining the skin biopsies. The authors acknowledge the support of the Spanish Ministry of Science and Innovation to the EMBL partnership, the Centro de Excelencia Severo Ochoa and the CERCA Programme/Generalitat de Catalunya and the Alexander v. Humboldt foundation. We acknowledge financial support from the following sources: Ministerio de Economía y Competitividad (SEV-2012-0208, BFU2013-44188-P, CSD2009-00016 to V.M.); Deutsche Forschungsgemeinschaft (ID 468236352) and CMMC Cologne to T.K and V.M. V.R. acknowledges financial support from the Ministerio de Ciencia y Innovacion through the Plan Nacional (PID2020-117011GB-I00). This project has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 951146). This publication is part of the Project TARTAFI (Ref. PDC2021-121870-I00), funded by MCIN/AEI/10.13039/501100011033 and the European Union “NextGenerationEU”/PRTR. This work was supported by the Fondation pour la Recherche Médicale, (FRM) AJE202210016216 to I.R. M.C, G.C, F.C, J.A, and PL-A acknowledge funding from Fundació CELLEX; Ministerio de Economıa y Competitividad - Severo Ochoa programme for Centres of Excellence in R&D (CEX2019-000910-S); CERCA programme and Laserlab-Europe (871124); Ministerio de Ciencia e Innovación (MCIN/AEI/10.13039/501100011033); and Fondo Social Europeo (PRE2020-095721, M.C). The SLN facility corresponds to a “Grup reconegut 2021 SGR 01456 pel Departament de Recerca i Universitats de la Generalitat de Catalunya”. F.C. acknowledges support from the Government of Spain (RYC-2017–22227, PID2019-106232RB-I00/10.13039/501100011033/110198RB-I00).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Editorial: Unconventional protein secretion: From basic mechanisms to dysregulation in disease

  • Chiritoiu, Marioara
  • Stewart, Sarah E.
  • Zhang, Min
  • Malhotra, Vivek
  • Villeneuve, Julien
MC acknowledges support from the Romanian Ministry of Research and Innovation, UEFISCDI grant TE156/2020 (PN-III-P1-1.1-TE-2019-1705). SES acknowledges support from the Australian Research Council, DE200100611. VM is an Institució Catalana de Recerca i Estudis Avançats professor at the Centre for Genomic Regulation. Work in the Malhotra lab is funded by grants from the Spanish Ministry of Economy and Competitiveness (Plan Nacional to VM: PID 2019-105518GB-I00) and the European Research Council Synergy Grant (ERC-2020-SyG - Proposal No. 951146). JV acknowledges support from the Fondation Vaincre Alzheimer, the association France Parkinson, CNRS, INSERM and the University of Montpellier.